Wockhardt recalls 13 drugs in US made at 2 units in MaharashtraWhen contacted, Wockhardt Chairman Habil Khorakiwala said the total number of drugs that are recalled in the US is 13.
Wockhardt to recall some drugs made in India after US FDA concernsThe FDA banned US exports from Wockhardt's Waluj and Chikalthana plants in central India in 2013, citing manufacturing quality lapses.
Dose of bitter pills, few booster injections for pharma sectorThe pharma sector, estimated to be around Rs 1.5 lakh cr, recorded single digit growth for the first time in many years on account of deepe...
Wockhardt's Chikalthana plant hit by USFDA import restrictionsIn May, the USFDA had also issued an import alert on the company's Waluj facility which makes injectables and solid dosages.
Wockhardt rallies 11% after UK regulator eased restrictions on Kadiya unitUKMHRA had imposed restrictions on import of medicines made at the Mumbai-based firm's unit at Kadaiya for violation of norms.
Profit booking grips Sensex; top seven stocks in actionThe S&P BSE Sensex witnessed profit booking for the third consecutive session. Here is a list of six stocks which are in focus in trade tod...
Six stocks in focus in Thursday morning tradeIndian markets are likely to trade in a range. Here is a list of six stocks which are likely to be in focus in trade today.
Wockhardt may face £1 million hit due to Kadaiya unit lapsesWockhardt today said it will take a revenue hit of nearly one million pounds due to import restrictions imposed by the UK health regulator ...
- J B Chemicals Q3 PAT up 28.95 pc to Rs 38.12 cr
J B Chemicals & Pharmaceuticals on Thursday said its profit after tax (PAT) rose by 28.95 per cent to Rs 38.12 crore for the third quarter ...